To The Moon

Log In/Sign Up

yong168

    • yong168yong168
      ·2023-08-03
      opioid and cannabis producers should invest in Adamis Pharmaceuticals: 1. Market Potential: Highlight the growing market demand for solutions to reduce opioid overdose deaths. With Adamis Pharmaceuticals' focus on R&D in this area, investing in the company could present a valuable opportunity to tap into a potentially lucrative market. 2. Positive Social Impact: Emphasize the positive social impact that reducing opioid overdose deaths can have on communities and families affected by addiction. By supporting Adamis Pharmaceuticals, these producers can contribute to saving lives and making a difference in the opioid crisis. 3. Diversification of Portfolio: Investing in a pharmaceutical company like Adamis can diversify their product portfolio and reduce dependency on a single industry. T

      Adamis stock soars as high as 480% amid asset sale, drug study news

      Shares of tiny Adamis Pharmaceuticals (NASDAQ:ADMP) rocketed as high as 480% early Tuesday in the wake of news that it had sold certain assets related to its shuttered pharmacy compounding business an
      Adamis stock soars as high as 480% amid asset sale, drug study news
      315Comment
      Report
    • yong168yong168
      ·2023-08-03
      opioid and cannabis producers should invest in Adamis Pharmaceuticals: 1. Market Potential: Highlight the growing market demand for solutions to reduce opioid overdose deaths. With Adamis Pharmaceuticals' focus on R&D in this area, investing in the company could present a valuable opportunity to tap into a potentially lucrative market. 2. Positive Social Impact: Emphasize the positive social impact that reducing opioid overdose deaths can have on communities and families affected by addiction. By supporting Adamis Pharmaceuticals, these producers can contribute to saving lives and making a difference in the opioid crisis. 3. Diversification of Portfolio: Investing in a pharmaceutical company like Adamis can diversify their product portfolio and reduce dependency on a single industry. T

      Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering

      SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation(NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the pricing of its public offering of 5,9
      Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
      203Comment
      Report
    • yong168yong168
      ·2023-08-02
      opioid and cannabis producers should invest in Adamis Pharmaceuticals: 1. Market Potential: Highlight the growing market demand for solutions to reduce opioid overdose deaths. With Adamis Pharmaceuticals' focus on R&D in this area, investing in the company could present a valuable opportunity to tap into a potentially lucrative market. 2. Positive Social Impact: Emphasize the positive social impact that reducing opioid overdose deaths can have on communities and families affected by addiction. By supporting Adamis Pharmaceuticals, these producers can contribute to saving lives and making a difference in the opioid crisis. 3. Diversification of Portfolio: Investing in a pharmaceutical company like Adamis can diversify their product portfolio and reduce dependency on a single industry. T

      Adamis Pharmaceuticals Units Drop 66% After $8M Offering Prices

      Adamis Pharmaceuticals units were down 66% at $1.37 after the company priced its public offering of 5.9 million units at $1.35 a unit.The stock closed Tuesday's session up 179% on no news, and is down 95% in the past 12 months.Each unit consists of one share of common stock and one warrant to buy one share of stock.The warrants will be immediately exercisable at an exercise price of $1.35 a share and will expire five years from the date of issuance. The shares of stock and accompanying warrants can only be purchased together in this offering, but will be issued separately and will be immediately separable upon issuance.Proceeds are expected to be $8 million. The offering is expected to close on Friday.
      Adamis Pharmaceuticals Units Drop 66% After $8M Offering Prices
      138Comment
      Report
    • yong168yong168
      ·2022-10-28
      [得意] 

      马斯克买推特，“华人首富”出巨资，扎克伯格心发虚

      马斯克会怎么让推特起死回生？非常值得期待。
      马斯克买推特，“华人首富”出巨资，扎克伯格心发虚
      559Comment
      Report
    • yong168yong168
      ·2022-10-27
      [财迷] 

      大涨638%！LogicBio(LOGC.US)与阿斯利康子公司达成收购协议

      智通财经APP获悉，10月3日，阿斯利康罕见病业务子公司Alexion宣布，已与Lexington公司(LOGC.US)达成最终收购协议。此次收购计划旨在通过LogicBio的独特技术、经验丰富的罕见病研发团队以及临床前开发方面的专业知识，快速加速Alexion在基因组药物领域的增长。受此消息影响，周一Lexington(LOGC.US)股价大涨637.61%。根据协议条款，Alexion将通过子公司发起现金收购要约，以每股2.07美元的价格收购LogicBio的所有流通股。双方董事会一致批准了该交易。Alexion计划在4到6周内完成交易，LogicBio员工将保留在当前职位。
      大涨638%！LogicBio(LOGC.US)与阿斯利康子公司达成收购协议
      314Comment
      Report
    • yong168yong168
      ·2022-04-07
      2023 yes...tesla ev maxpro for the market  "go green"country..almost
      446Comment
      Report
    • yong168yong168
      ·2022-03-17
      🥶💸

      今年加息7次，美联储能做到吗？

      部分经济学家对美联储加息7次的预期表示怀疑，认为他们是否真的采取行动，是一个悬而未决的问题。美联储激进的加息计划，可能会在对抗通胀的同时使经济陷入衰退。周三，美联储将利率上调了25个基点，这是自201
      今年加息7次，美联储能做到吗？
      654Comment
      Report
    • yong168yong168
      ·2022-03-03
      🤭

      ”特斯拉杀手“宣布涨价后，预订用户纷纷取消订单

      Rivian旗下一些车型涨价幅度超过12000美元，有些甚至达到2万美元。
      ”特斯拉杀手“宣布涨价后，预订用户纷纷取消订单
      606Comment
      Report
    • yong168yong168
      ·2022-03-01
      💸
      Sorry, this post has been deleted
      638Comment
      Report
    • yong168yong168
      ·2022-03-01
      🏃🏽‍♂️
      Sorry, this post has been deleted
      603Comment
      Report
    • empty
      No following yet
       
       
       
       

      Most Discussed

       
       
       
       
       

      Terms and Conditions·Privacy Policy

      Company: TTMF Limited. Tech supported by Xiangshang Yixin.

      Email：uservice@ttm.financial